Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1

Journal of Clinical Endocrinology and Metabolism

Volumn 77, Issue 4, 1993, Pages 976-981

  Johansson, Bo Lennart ^a   Kernell, Anna ^b   Sjoberg, Stefan ^a   Wahren, John ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FRUCTOSAMINE; HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FUNCTION; MALE; METABOLIC REGULATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; URINARY EXCRETION;

ADOLESCENT; ADULT; ALBUMINURIA; BLOOD GLUCOSE; BLOOD-RETINAL BARRIER; C-PEPTIDE; DIABETES MELLITUS, INSULIN-DEPENDENT; DOUBLE-BLIND METHOD; FEMALE; FLUORESCEIN; FLUORESCEINS; FRUCTOSAMINE; GLOMERULAR FILTRATION RATE; GLUCAGON; GROWTH HORMONE; HEMOGLOBIN A, GLYCOSYLATED; HEXOSAMINES; HUMAN; INSULIN; INSULIN INFUSION SYSTEMS; KIDNEY; MALE; NOREPINEPHRINE; PILOT PROJECTS; SUPPORT, NON-U.S. GOV'T;

GLOMERULUS;

EID: 0027527613     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jcem.77.4.8408474     Document Type: Article

References (23)

1. Steiner D. 1978 On the role of the proinsulin C-peptide. Diabetes. 27:(Suppl 1):145-148.
2. Kitabchi AE. 1977 Proinsulin and C-peptides: a review. Metabolism. 26:547-587.
3. Johansson B-L, Linde B, Wahren J. 1992 Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm in type 1 (insulin-dependent) diabetic patients. Diabetologia. 35:1151-1158.
4. Johansson BL, Sjöberg S, Wahren J. 1992 The influence of C-peptide on glucose utilization and kidney function in IDDM patients. Diabetologia. 35:121-128.
5. Sjöberg S, Johansson B-L, Östman J, Wahren J. 1991 Renal and splanchnic exchange of human biosynthetic C-peptide in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 34:423-428.
6. Wallberg-Henriksson H, Andréasson K, Galuska D, Johansson B-L, Thorne A, Sonnenfeld T. 1989 C-Peptide stimulates glucose transport in incubated normal muscle but not in muscle from type 2 (non-insulin-dependent) diabetic patients [Abstract], Diabetologia. 32:555A.
7. Zierath JR, Thorne A, Johansson B-L, Wallberg-Henriksson H. 1990 C-Peptide stimulates glucose transport in type I diabetic skeletal muscle [Abstract], Diabetes. 39(Suppl 1): 141 A.
8. Johnson RN, Metcalf PA, Baker JR. 1982 Fructosamine a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta. 127:87-95.
9. Arnqvist H, Olson PO, Von Schenk H. 1987 Free and total insulin determined after precipitation with polyethylene glycol: analytic characteristics and effects of sample handling and storage. Clin Chem. 33:93-96.
10. Faloona GR, Unger RH 1974 Glucagon. In: Jaffe, Behnmer, eds. Methods of hormone radioimmunoassay. New York, London: Academic Press; pp 317-330.
11. Hjemdal P, Odeskog H, Kahan T. 1979 Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection; comparison with a radioenzymatic method. Life Sei. 25:131-138.
12. Johansson B-L, Berg U, Bohlin A-B, Lefvert A-K, Freyschuss U. 1987 Exercise-induced changes in renal function and their relation to plasma noradrenaline in insulin-dependent diabetic children and adolescents. Clin Sei. 72:611-620.
13. Blom M, Hjörne N. 1971 Immunochemical determination of serum albumin with a centrifugal analyses. Clin Chem. 21:195-198.
14. Kernell A, Tenland T. 1982 Vitreous fluorophotometry-an evaluation of an instrument for the study of diabetic retinopathy. Innov Tech Biol Med. 3:320-327.
15. Polonsky KS, Given BD, Van Cauter E. 1988 Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 81:442-448.
16. Kernell A, Larsson Y, Ludvigsson J, Tenland T. 1980 Vitreous fluorophotometry in juvenile diabetes. Acta Endocrinol (Copenh). 94(Suppl 238):67-74.
17. Kernell A, Ludvigsson J. 1985 Blood-retinal barriers in juvenile diabetics in relation to early clinical manifestations. Graefes Arch Clin Exp Ophthalmol. 222:250-253.
18. Kernell A, Ludvigsson J, Finnström K. 1990 Vitreous fluorophotometry in juvenile diabetics with and without retinopathy in relation to metabolic control: insulin antibodies and C-peptide levels. Acta Ophthalmol. 68:415-420.
19. Kohner EM, Lawson PM, Ghosh G, Teata M, Kroc coiloborative study group. 1985 Assessment of fluorescein angiograms. Diabetes. 35(Suppl 3):56-60.
20. White NH, Waltman SR, Krupin T, Santiago JV. 1982 Reversal of abnormalities in ocular fluorophotometry in insulin-dependent diabetes after five to nine months of improved metabolic contiol. Diabetes. 31:80-85.
21. Blair NP, Evans MA, Lesar TS, Willet M. 1989 Plasma fluorescein and fluorescein glucoronide in patients with selected eye diseases. Graefe Arch Clin Exp Ophthalmol. 227:114-117.
22. Blair NP, Evans MA, Lesar TS, Zehner RC. 1986 Fluorescein glucoronide pharmacokinetics after intrevenous injection. Invest Ophthalmol Vis Sei. 27:1107-1114.
23. Zierath JR, Galuska D, Johansson B-L, Wallberg-Henriksson H. 1991 Effect of human C-peptide on glucose transport in in vitro incubated human skeletal muscle. Diabetologia. 34:899-901.